Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Sponsored by Intra-Cellular Therapies, Inc.
About this study
This is a multicenter, randomized, double-blind, placebo-controlled parallel-group, fixed-dose study in patients with a primary diagnosis of MDD according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) who have an inadequate response to ongoing ADT.
Enrolling at this location
DM Clinical Research
Houston, Texas
I'm interestedThis study also enrolls at 24 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.